SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : IGT Pharma (V.IGT) Anti-Cancer Blockbuster!! -- Ignore unavailable to you. Want to Upgrade?

To: Red Hill who wrote (59)2/11/1999 7:57:00 AM
From: Stephen O  Read Replies (1) | Respond to of 86
 
Companies with a drug in Phase 1 Human testing generally command a market cap of $75-$100 million. The market cap of IGT is a miniscule $7 million. The first person will be injected very soon. perhaps that announcement will wake things up.



To: Red Hill who wrote (59)2/11/1999 12:29:00 PM
From: Bruce Lock  Respond to of 86
 
I'm with you RED !!!

It's all a matter of time.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News